BRUSSELS — The European Union has filed a lawsuit in Belgium towards the pharmaceutical firm AstraZeneca over what it says is a breach of contract within the firm’s supply of Covid-19 vaccine, the European Fee introduced on Monday.
The bloc’s relationship with the corporate has soured quickly since AstraZeneca mentioned in January that it wouldn’t be capable of ship on its scheduled vaccine doses for the primary quarter of the yr, setting the area’s vaccination marketing campaign again by weeks.
“The fee has began final Friday a authorized motion towards the corporate AstraZeneca on the premise of breaches of the superior buy settlement,” mentioned Stefan de Keersmaecker, a spokesman on well being points for the fee, the E.U.’s govt department. “The explanation certainly being that the phrases of the contract, or some phrases of the contract, haven’t been revered and the corporate has not been ready to provide you with a dependable technique to make sure the well timed supply of doses.”
Mr. de Keersmaecker mentioned that every one 27 E.U. member nations supported the transfer.
The corporate, whereas acknowledging that manufacturing issues have induced delays, has mentioned its failure to ship shouldn’t be a breach of contract, as a result of the European Union had positioned its order after different purchasers, most notably Britain. A spokesman for the corporate didn’t instantly reply to a request for touch upon Monday.